Minute Insight: SpectralMD Signs Another Contract With BARDA, Worth $149m
The diagnostic company has secured more government funding for DeepView, a product it has developed to assess the healing of certain types of wound. In total, BARDA has supported SpectralMD with almost a quarter of a billion dollars.
You may also be interested in...
The Dallas-based company is using its DeepView technology to aid the treatment of hard-to-heal and chronic wounds.
Medtronic is dropping plans to acquire EOFlow, which has faced numerous patent lawsuits from Insulet.
The Belgian start-up is developing a scleral contact lens with an inbuilt LCD screen capable of filtering light – offering a non-surgical solution to a variety of ophthalmic conditions.